Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)
NCT06568172 · RECRUITING · Phase 3
1 clinical trials found for Eyelid Squamous Cell Carcinoma.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
There are 1 clinical trials listed for Eyelid Squamous Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Eyelid Squamous Cell Carcinoma trials are distributed across: Phase 3 (1).